Podcast
Two Onc Docs
Hosted by Sam and Karine · EN
This is Sam and Karine, and we are Two Onc Docs! We both graduated from our Heme/Onc fellowships in 2021 and became board certified in both Hematology and Oncology. Our mission with Two Onc Docs is to create short board review episodes that you can listen to on your drive to work, while you make your morning coffee, or between pages on call. This is intended to be a supplement to other established board studying resources for busy trainees. *This podcast is intended to be an educational resource for health care providers.*
43episodes
Episodes
Newest firstAll episodes
Testicular Cancer 2025 UPDATE Part 1 (Seminoma)
Apr 14, 202500:12:01Tap to summarizeThis week’s episode is part 1 of testicular cancer 2025 updates. We had the honor of interviewing Dr. Larry Einhorn a true legend when it comes to the management of testicular CA last year, released in April 2024, but today, we will be repeating a quick overview of risk factors and staging for testicular cancer, as well as the management of seminoma.
Transcribe →Chronic Lymphocytic Leukemia (CLL) 2025 UPDATE
Mar 31, 202500:12:42Tap to summarizeThis week’s episode will be focusing on an update of CLL. We will go over important details on the presentation, diagnosis, prognostic factors, and treatment options for initial and refractory disease, as well as key toxicities.
Transcribe →Metastatic Prostate Cancer x Dr. Charles Ryan 2025 UPDATE
Mar 24, 202500:34:53Tap to summarizeWe are so excited to welcome back Dr. Charles (Chuck) Ryan for our 2025 prostate cancer updates. Dr. Ryan is an internationally recognized GU oncologist and prostate cancer expert, seeing patients at MSK in NYC, and co-host of the podcast 'The Good News About Cancer'. This episode will cover metastatic prostate cancer including board review pearls & key toxicities of treatments, upcoming exciting research in PCa, and advice for trainees/early career faculty.
Transcribe →Localized Prostate Cancer x Dr. Charles Ryan 2025 UPDATE
Mar 18, 202500:35:49Tap to summarizeWe are so excited to welcome Dr. Charles (Chuck) Ryan for our 2025 prostate cancer updates. Dr. Ryan is an internationally recognized GU oncologist and prostate cancer expert, seeing patients at Memorial Sloan Kettering in NYC. This episode will cover localized prostate cancer, risk factors, staging, role of PET PSMA, risk stratification, treatments, as well as introduce biochemical recurrence.
Transcribe →Metastatic Colon Cancer 2025 UPDATE
Mar 11, 202500:23:45Tap to summarizeToday’s episode is focusing on what you need to know regarding metastatic colon cancer. This will include the need to know about molecular studies, treatment, and surgery for oligometastatic disease. There has been three breakthroughs since we last covered this topic in the treatment of metastatic CRC based on molecular findings that we will go over today.
Transcribe →Localized Colon Cancer 2025 UPDATE
Mar 3, 202500:21:07Tap to summarizeToday’s episode is focusing on what you need to know regarding early stage colorectal cancer (CRC) as of 2025. The last time we covered this topic was in 2023 and things continue to change. We will go over all the important details on the diagnosis, presentation, diagnostic work-up, role of ctDNA, staging, treatment, and surveillance of localized CRC.
Transcribe →Multiple Myeloma 2025 x Dr. Vincent Rajkumar Part 2
Feb 24, 202500:19:13Tap to summarizeWe are so honored to welcome back Dr. S. Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, Minnesota. He is also Editor-In-Chief of Blood Cancer Journal and the Chairperson of the Board of the International Myeloma Foundation. This week’s episode will be focusing on additional pearls for the treatment of Multiple Myeloma including options for refractory disease, as well as advice for trainees.
Transcribe →ASCO GU 2025 Takeaways
Feb 18, 202500:13:22Tap to summarizeToday we will be discussing a few of the exciting abstracts presented at ASCO GU (Feb 13-15 2025) for prostate CA (TALAPRO-2), bladder CA (EV-302, CM-274, NIAGARA), and RCC (COSMIC-313, KIM-1).
Transcribe →ASCO GU 2025 Preview
Feb 10, 202500:10:46Tap to summarizeToday we will be discussing exciting data to come at ASCO GU (Feb 13-15 2025) in terms of research for prostate CA, bladder CA, RCC and other rarer GU tumors.
Transcribe →Multiple Myeloma 2025 x Dr. Vincent Rajkumar Part 1
Feb 3, 202500:17:34Tap to summarizeWe are so honored to welcome Dr. S. Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, Minnesota. He is also Editor-In-Chief of Blood Cancer Journal and the Chairperson of the Board of the International Myeloma Foundation. This week’s episode will be focusing on Multiple Myeloma symptoms, diagnostic criteria, work-up and initial treatment.
Transcribe →